EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?

B W L C M Broeders iD, F Carbone, L M Balsiger, J Schol, K Raymenants iD, I Huang, A Verheyden, T Vanuytsel iD, J Tack iD

Alimentary Pharmacology & Therapeutics · 2023-04 · 57 (8) · 851-860

DOI: 10.1111/apt.17414 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2023-03. Verfasst von B W L C M Broeders und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Dyspepsia, Duodenal Diseases, Eosinophilia. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 98 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Functional dyspepsia (FD) is one of the most frequent conditions in gastroenterological outpatient health care. Most recent research in FD has shifted its focus to duodenal pathophysiological mechanisms, although current treatments still focus mainly the stomach.

Aim

The aim of the study was to provide a comprehensive overview of the pathophysiology of FD focusing on a paradigm shift from gastric towards duodenal mechanisms.

Methods

We conducted a literature search in PubMed for studies describing mechanisms that could possibly cause FD.

Results

The pathophysiology of FD remains incompletely understood. Recent studies show that duodenal factors such as acid, bile salt exposure and eosinophil and mast cell activation correlate with symptom pattern and burden and can be associated with gastric sensorimotor dysfunction. The evolving data identify the duodenum an interesting target for new therapeutic approaches. Furthermore, the current first‐line treatment, that is proton pump inhibitors, reduces duodenal low‐grade inflammation and FD symptoms.

Conclusion

Future research for the treatment of FD should focus on the inhibition of duodenal mast cell activation, eosinophilia and loss of mucosal integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyspepsiaDuodenal DiseasesEosinophiliaHumansDuodenumEosinophils

Autor:innen und Institutionen

  • Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
  • Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.

ORCID-Profile: B W L C M Broeders, K Raymenants, T Vanuytsel, J Tack

Zitieren

APA

Broeders, B. W. L. C. M., Carbone, F., Balsiger, L. M., Schol, J., Raymenants, K., Huang, I., Verheyden, A., Vanuytsel, T., & Tack, J. (2023). Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?. Alimentary Pharmacology & Therapeutics, 57(8), 851-860. https://doi.org/10.1111/apt.17414

Vancouver

Broeders BWLCM, Carbone F, Balsiger LM, Schol J, Raymenants K, Huang I, et al. Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?. Alimentary Pharmacology & Therapeutics. 2023;57(8):851-860. doi:10.1111/apt.17414

BibTeX
@article{Broeders2023,
  author = {Broeders, B W L C M and Carbone, F and Balsiger, L M and Schol, J and Raymenants, K and Huang, I and Verheyden, A and Vanuytsel, T and Tack, J},
  title = {Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both?},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  volume = {57},
  number = {8},
  pages = {851--860},
  doi = {10.1111/apt.17414}
}
Kostenlos starten →